Laddar...
A peripherally selective diphenyl purine antagonist of the CB1 receptor
Antagonists of the CB1 receptor can be useful in the treatment of several diseases including obesity, diabetes, and liver disease. However, to date, the only clinically approved CB1 receptor antagonist, rimonabant, was withdrawn due to adverse CNS related side effects such as depression and suicidal...
Sparad:
| I publikationen: | J Med Chem |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4281022/ https://ncbi.nlm.nih.gov/pubmed/24041123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm401129n |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|